Atlas Venture is an early stage venture capital firm investing in biotech innovation.
Phone: 617-588-2600
25 First Street
Suite 303
Cambridge, 02141
Massachusetts, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-09-21 | X4 Pharmaceuticals | Series B - II | $8M | |
| 2018-07-19 | IFM Tre | Series A | $31M | Abingworth, Bristol-Myers Squibb, and IFM Therapeutics |
| 2018-07-17 | HotSpot Therapeutics | Series A | $45M | Sofinnova Partners |
| 2018-07-04 | Cadent Therapeutics | Seed VC | $25M | Access Industries, Cowen Group, and Qiming Venture Partners |
| 2018-06-25 | Akero Therapeutics | Series A | $65M | Apple Tree Partners, venBIO, and Versant Ventures |
